Protara Therapeutics share price logo

Protara Therapeutics

NASDAQ: TARA

$3.22

-0.03

(-0.92%)

Live

as on

Protara Therapeutics Stock Performance

as on September 30, 2026 at 1:09 am IST

  • Day's Low

    Day's High

    $3.21
    $3.33
    downward going graph

    0.31%

    Downside

    3.42%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.19
    $7.82
    downward going graph

    0.93%

    Downside

    142.86%

    Upside

    downward going graph

Protara Therapeutics share price movements today

Previous Close
$3.25
Open
$3.28
Volume
31.4K
Market Cap
$193.8M
Day's Low - High
$3.21 - $3.33
52 Week Low - High
$3.19 - $7.82

Protara Therapeutics Historical Returns

1 Month Return
-14.92 %
3 Month Return
-21.88 %
1 Year Return
-26.3 %
3 Year Return
+ 94.61 %
5 Year Return
-52.55 %

Protara Therapeutics Stock Fundamentals & Key Indicators

Check Protara Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$193.8M

EPS (TTM)

-1.36

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.41

Industry PE ratio

-2.66

PEG Ratio

-0.14294671264265976

EBITDA

-69.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-41.72%

Protara Therapeutics Stock Valuation

Track how Protara Therapeutics P/E has moved over time to understand its valuation trends.

Protara Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-3.98x)

December 31, 2025

Today (-3.98x)

December 31, 2025

Industry (-2.66x)

December 31, 2025

Highest (-0.46x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.98x

Protara Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protara Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$193.8M-52.55%-2.410.00%0.00%
StrongBuy$43.9B628.83%-23.130.00%0.00%
Neutral$79.4B-47.93%-24.92-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B23.99%18.8284.86%0.47%

Stock Returns calculator for Protara Therapeutics Stock including INR - Dollar returns

The Protara Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Protara Therapeutics investment value today

Current value as on today

₹79,005

Returns

-₹20,995

(-20.99%)

Returns from Protara Therapeutics Stock

-₹26,984 (-26.98%)

Dollar Impact

₹5,989 (+5.99%)

Analyst Recommendation on Protara Therapeutics Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Protara Therapeutics. Average target price of $25.71

Protara Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Protara Therapeutics.

What analysts predicted

87.48%UPSIDE

Target Price

$25.71

Current Price

$3.22

Analyzed by

4 Analysts

High

$27

Target

$25.71

Low

$20

Protara Therapeutics target price $25.71, a slight upside of 87.48% compared to current price of $3.22. According to 4 analysts rating.

Indian Investors' Interest in Protara Therapeutics Stock

Search interest for Protara Therapeutics Stock has increased by 530% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:530% versus previous 30 day period

Protara Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
-
-
-
0
-
Operating Income
-11
-10
-12
-14
-14
-16
-14
-19
-19
-23
EBITDA
-11
-9
-11
-12
-11
-14
-13
-17
-17
-21
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-9
-11
-12
-11
-14
-13
-17
-17
-21
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-11
-9
-11
-12
-11
-14
-13
-17
-17
-21
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Protara Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
0
-
0
Operating Income
-30
-26
-15
-34
-47
-67
-43
-49
-64
EBITDA
-29
-20
-7
-33
-45
-64
-40
-44
-57
Interest Expense
0
-
-
0
1
1
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-29
-25
-14
-33
-47
-65
-40
-44
-57
Income Tax Expense
-
5
0
-
-
-
-
-
-
Net Income
-29
-25
-14
-33
-47
-65
-40
-44
-57
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Protara Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-9
-11
-12
-11
-14
-13
-17
-17
-21
Operating Cash Flow
-10
-7
-8
-9
-14
-12
-12
-16
-21
-14
Investing Cash Flow
23
2
-29
22
-58
-47
-6
-26
-14
17
Financing Cash Flow
0
42
-
97
1
0
0
80
1
-1
Change in Cash
12
37
-37
111
-71
-59
-18
37
-34
2

Protara Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-20
-14
-33
-47
-65
-40
-44
-57
Operating Cash Flow
-22
-23
-15
-23
-34
-26
-37
-35
-56
Investing Cash Flow
-16
18
2
2
-98
14
53
19
-139
Financing Cash Flow
23
2
0
189
0
0
0
139
82
Change in Cash
-15
-1
-13
168
-132
-11
15
123
-113

Mutual Funds that own Protara Therapeutics Stock

Check out the Mutual Funds with significant holdings in Protara Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.492193%
2063729
Fidelity Salem Street Trust
0.979242%
578688
Fidelity Concord Street Trust
0.607396%
358944
DFA INVESTMENT DIMENSIONS GROUP INC
0.44393%
262343
VANGUARD SCOTTSDALE FUNDS
0.345378%
204103

Global Institutional Holdings in Protara Therapeutics

Funds
Holdings
Vanguard
4.39%
Stephen A. Schwarzman
3.83%
VANGUARD INDEX FUNDS
3.49%
iShares
3.45%
Richard Driehaus
2.13%

Insights on Protara Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TARA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 678.8% return, outperforming this stock by 705.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TARA stock has moved down by -11.7%

About Protara Therapeutics

Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of lymphatic malformations. Furthermore, Protara is developing intravenous choline chloride, a potential phospholipid substrate replacement therapy aimed at addressing liver disease associated with intestinal failure. The organization, which was formerly known as ArTara Therapeutics, Inc., underwent a name change to Protara Therapeutics, Inc. in May 2020. Its principal operations are based in New York, New York.
OrganisationProtara Therapeutics
Headquarters345 Park Avenue South, New York City, NY, 10010, US
IndustryBiotechnology
CEOJesse Shefferman
E-voting on sharesClick here to vote

Key Management of Protara Therapeutics

Name

Title

Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D.

Co-Founder, Chief R&D Officer

Mr. Patrick Fabbio M.B.A.

Chief Financial Officer

Ms. Justine O'Malley

Senior Vice President of Investor Relations & Corporate Affairs

Dr. Shane Williams Ph.D.

Chief People Officer

Mr. Jesse Shefferman

Co-founder, CEO, President & Director

Ms. Mary J. Grendell J.D.

General Counsel & Corporate Secretary

Mr. William Conkling

Chief Commercial Officer

Carla Beckham M.D., Ph.D.

Lead Medical Director, Head of Clinical Development of TARA-002 in NMIBC & Board-Certified Urologist

Dr. Neal D. Shore F.A.C.S., M.D.

Medical Director of START Carolinas/ Carolina Urologic Research Center

Ms. Hannah Fry

VP, Principal Accounting Officer & Controller

FAQs

What is Protara Therapeutics share price today?

Protara Therapeutics share price today is $3.22 as on . Protara Therapeutics share today touched a day high of $3.33 and a low of $3.21.

What is the 52 week high and 52 week low for Protara Therapeutics share?

Protara Therapeutics share touched a 52 week high of $7.82 on and a 52 week low of $3.19 on . Protara Therapeutics stock price today i.e. is trending at $3.22,which is 58.82% down from its 52 week high and 0.94% up from its 52 week low.

What is Protara Therapeutics's market capitalisation today?

Protara Therapeutics market capitalisation is $0.00T as on .

How to invest in Protara Therapeutics Stock (TARA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Protara Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protara Therapeutics Shares that will get you 0.4658 shares as per Protara Therapeutics share price of $3.22 per share as on September 29, 2026 at 7:39 pm IST.

What is the minimum amount required to buy Protara Therapeutics Stock (TARA) from India?

Indian investors can start investing in Protara Therapeutics (TARA) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Protara Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Protara Therapeutics share’s latest price of $3.22 as on September 29, 2026 at 7:39 pm IST, you will get 3.1056 shares of Protara Therapeutics. Learn more about fractional shares .

What are the returns that Protara Therapeutics has given to Indian investors in the last 5 years?

Protara Therapeutics stock has given -52.55% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?